Outcomes of nerve autografting are often merely adequate to poor, especially as the nerve gap increases in length. We hypothesize senescent cells accumulate in longer grafts and resultant changes in protein expression contribute to reduced regeneration.
RESULTS:
Axon counts clearly demonstrated disproportionately reduced regeneration in the longer graft compared to the short graft when measuring at equivalent distances to the spinal cord: the number of regenerated axons in the long graft was 57% of those regenerated in the short graft. Additionally, retrograde labeling showed significantly fewer motoneurons were found to be regenerating axons to long grafts compared to the short graft repairs. Cell composition amongst the different grafts and injured nerve were surprisingly consistent: groups had similar total numbers of cells and similar proportions of fibroblasts, Schwann cells, and macrophages. Immunohistochemical analysis showed an increased percentage of cells with senescent markers in the long grafts and in the "normal" nerve proximal to the graft. While gene expression for senescent markers was increased in both long and short nerve grafts, these markers remained elevated over time in the long grafts. Interestingly, GDNF and IL-6 expression was elevated in the long grafts compared to the short. Finally, immunohistochemistry revealed increased NOTCH signalling in the long grafts.
CONCLUSION:
Comparison of short and long grafts, at points equidistant to the spinal cord, showed reduced axon regeneration and reduced number of motoneurons regenerating axons. Given this reduced regeneration in the presence of a long graft and the finding that cellular composition was unchanged, immunohistochemistry and gene expression were used to identify gene and protein expression differences in the grafts.The longer grafts were found to have a greater proportion of senescent cells and the nerve proximal to the graft even showed senescent changes. Gene expression associated with senescent was increased in the grafts but retained over time in the longer grafts. Prior work has linked increased NOTCH signalling to reduced neurite extension from dorsal root ganglia neurons and the current work links increasing graft length with increased NOTCH signalling. These protein and gene expression changes give insight as to the poor clinical outcomes associated with autografts and provide targets for improvement.
PURPOSE:
The prevention of heterotopic ossification (HO) is limited by inadequate detection of ectopic bone formation at early time points during which prophylaxis must be initiated in order to be effective. Current imaging modalities are costly, invasive, and unable to visualize HO prior to six weeks after bone formation. Therefore, these technologies are not utilized, and patients receive treatment in a delayed fashion as a result of these diagnostic inadequacies. In this study, we validate the use of spectroscopic ultrasound imaging (SUSI) to diagnose HO as early as one week after injury, and five weeks earlier than microCT imaging which is the current gold standard.
METHODS:
Concurrent SUSI and microCT were performed after an Achilles tenotomy and 30% total body surface area burn (C57BL6 mice; n=4 per time point). Imaging of the injured limb and skin incision only contra-lateral limb (control) was performed weekly (1-9 weeks post-injury) in a longitudinal fashion. Acoustic concentration (10*log(mm-3)) was calculated for each ultrasound frame. Houndsfield units were used to calculate HO volume on microCT imaging. Histology was used to confirm the presence of HO and to correlate with imaging findings at each time point.
RESULTS:
Using SUSI, the acoustic concentration of bone was significantly different than that of muscle, cartilage, and tendon (61.3 ± 7.3 vs. 36.5 ± 8.6 vs. 49.5 ± 5.4 vs. 39.8 ± 0.67; p<0.05). HO was visualized on SUSI as early as 1 week after injury and 5 weeks prior to detection by MicroCT. The acoustic concentration of HO was significantly greater than that of the control limb (56.9 ± 10.9 vs. 29.0 ± 10.7; p<0.05) at all time points. The surrounding edema also had a significantly lower acoustic concentration than the foci of HO (28.9 ± 5.6 vs. 56.9 ± 10.9; p<0.05), allowing for clear anatomic and structural delineation within this region. Spectroscopic foci of HO present at 1 week within the left limb correlated with the HO present at 9 weeks on microCT and histology.
CONCLUSION:
Spectroscopic ultrasound visualizes HO as early as one week after injury. As prophylaxis must be initiated within 1-3 weeks of initial HO formation to prevent the need for surgery, SUSI represents the ideal imaging modality to guide treatment. Additionally, SUSI can be used to monitor the progression of HO to measure when growth has halted in preparation for surgical excision. 
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PURPOSE:
Modern prosthetic limbs have reaped the benefits of the Digital Age, with improvements in materials, degrees of freedom and computational power. What has lagged behind these advances, is the ability of the recipient to control these devices. Neural interfaces are devices that aim to bridge the gap between the biological tissues and the robotic prosthetic. In most cases, the neural interface is placed on the skin, actuated by myoelectric signals highly susceptible to motion artifact and muscle signal crosstalk, ultimately preventing widespread clinical application. In 1943 Edwin Boldrey first published the transposition of nerve in bone to treat amputation neuromas. This method is still in use today, under the fundamental principal that placing the nerve in bone protects the neuroma from the mechanical and electrical stimuli that causes neuropathic pain. By redirecting transected nerves into the medullary cavity of long bones, the terminal end of the nerve is protected from external stimuli, whilst also providing direct access to the highly vascular stem cell niece. This already established surgical model presents the perfect in vivo bioreactor for the potential interfacing of transected nerves and electronic prosthetic devices. The research objectives of this pilot study were to create an animal model -termed the Osseointegrated Neural Interface (ONI), utilizing histology to demonstrate the stability and health of the nerve and surrounding tissues and electrophysiology to demonstrate nerve conductivity.
METHODS:
Transfemoral amputation was performed in New Zealand white rabbits. Briefly, the sciatic nerve was isolated and severed above the point of bifurcation. The femur was amputated at the midpoint and the nerve passed through a corticotomy. The terminal end of the nerve was sutured into a PDMS nerve sleeve, representing a mock electrode, which was pressed back into the opening of the medullary cavity forming a tight seal. The muscle and skin were closed over the femur. Animals were explored at 5 weeks via histology and electrophysiology.
RESULTS:
Gross examination of the ONI limb demonstrates that the nerve is stable at 5 weeks. Healthy nerve morphology can be identified by Schwann cells (S100+) along the length of the transected nerve. Cross sections of proximal portions of the nerve demonstrate the ONI nerve contains smaller myelinated axons when compared to the contralateral healthy sciatic nerve. Electrophysiology demonstrates that the nerve is alive within the bone,
